BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 22370857)

  • 1. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community.
    Savitz DA; Stein CR; Bartell SM; Elston B; Gong J; Shin HM; Wellenius GA
    Epidemiology; 2012 May; 23(3):386-92. PubMed ID: 22370857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome.
    Stein CR; Savitz DA; Dougan M
    Am J Epidemiol; 2009 Oct; 170(7):837-46. PubMed ID: 19692329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts.
    Winquist A; Steenland K
    Epidemiology; 2014 Mar; 25(2):255-64. PubMed ID: 24407430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure.
    Barry V; Darrow LA; Klein M; Winquist A; Steenland K
    Environ Res; 2014 Jul; 132():62-9. PubMed ID: 24742729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-Ohio Valley.
    Savitz DA; Stein CR; Elston B; Wellenius GA; Bartell SM; Shin HM; Vieira VM; Fletcher T
    Environ Health Perspect; 2012 Aug; 120(8):1201-7. PubMed ID: 22450153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley.
    Steenland K; Zhao L; Winquist A; Parks C
    Environ Health Perspect; 2013 Aug; 121(8):900-5. PubMed ID: 23735465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.
    Worley RR; Yang X; Fisher J
    Toxicol Appl Pharmacol; 2017 Sep; 330():9-21. PubMed ID: 28684146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital anomalies, labor/delivery complications, maternal risk factors and their relationship with perfluorooctanoic acid (PFOA)-contaminated public drinking water.
    Nolan LA; Nolan JM; Shofer FS; Rodway NV; Emmett EA
    Reprod Toxicol; 2010 Apr; 29(2):147-55. PubMed ID: 19897029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water.
    Nolan LA; Nolan JM; Shofer FS; Rodway NV; Emmett EA
    Reprod Toxicol; 2009 Jun; 27(3-4):231-238. PubMed ID: 19049861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers.
    Winquist A; Lally C; Shin HM; Steenland K
    Environ Health Perspect; 2013 Aug; 121(8):893-9. PubMed ID: 23735518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluorooctanoic acid exposure and natural menopause: A longitudinal study in a community cohort.
    Dhingra R; Darrow LA; Klein M; Winquist A; Steenland K
    Environ Res; 2016 Apr; 146():323-30. PubMed ID: 26802619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005-2010.
    Darrow LA; Stein CR; Steenland K
    Environ Health Perspect; 2013 Oct; 121(10):1207-13. PubMed ID: 23838280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PFOA and PFOS serum levels and miscarriage risk.
    Darrow LA; Howards PP; Winquist A; Steenland K
    Epidemiology; 2014 Jul; 25(4):505-12. PubMed ID: 24807698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant.
    Barry V; Winquist A; Steenland K
    Environ Health Perspect; 2013; 121(11-12):1313-8. PubMed ID: 24007715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability and epistemic uncertainty in water ingestion rates and pharmacokinetic parameters, and impact on the association between perfluorooctanoate and preeclampsia in the C8 Health Project population.
    Avanasi R; Shin HM; Vieira VM; Bartell SM
    Environ Res; 2016 Apr; 146():299-307. PubMed ID: 26796985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility.
    Hoffman K; Webster TF; Bartell SM; Weisskopf MG; Fletcher T; Vieira VM
    Environ Health Perspect; 2011 Jan; 119(1):92-7. PubMed ID: 20920951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community.
    Seals R; Bartell SM; Steenland K
    Environ Health Perspect; 2011 Jan; 119(1):119-24. PubMed ID: 20870569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between perfluorooctanoic acid exposure and strokes in a large cohort living near a chemical plant.
    Simpson C; Winquist A; Lally C; Steenland K
    Environ Res; 2013 Nov; 127():22-8. PubMed ID: 24199934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluorooctanoate exposure and major birth defects.
    Stein CR; Savitz DA; Elston B; Thorpe PG; Gilboa SM
    Reprod Toxicol; 2014 Aug; 47():15-20. PubMed ID: 24803403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA.
    Steenland K; Tinker S; Shankar A; Ducatman A
    Environ Health Perspect; 2010 Feb; 118(2):229-33. PubMed ID: 20123605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.